Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 20/20 | 0.84 |
| ▸ | EML4 | Q9HC35 | 3/20 | 0.79 |
| ▸ | KDR | P35968 | 3/20 | 0.78 |
| ▸ | SRPK2 | P78362 | 2/20 | 0.77 |
| ▸ | SRPK1 | Q96SB4 | 2/20 | 0.77 |
| ▸ | GAK | O14976 | 1/20 | 0.75 |
| ▸ | ACOX3 | O15254 | 1/20 | 0.75 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.75 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.75 |
| ▸ | EGFR | P00533 | 1/20 | 0.75 |
| ▸ | ESR1 | P03372 | 1/20 | 0.75 |
| ▸ | PGR | P06401 | 1/20 | 0.75 |
| ▸ | RET | P07949 | 1/20 | 0.75 |
| ▸ | ROS1 | P08922 | 1/20 | 0.75 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.75 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.75 |
| ▸ | FER | P16591 | 1/20 | 0.75 |
| ▸ | EPHA1 | P21709 | 1/20 | 0.75 |
| ▸ | DRD1 | P21728 | 1/20 | 0.75 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL898317 | 0.93 | ALK (0.92) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL29962747 | 0.93 | ALK (0.92) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL898216 | 0.92 | ALK (0.95) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL1703593 | 0.92 | ALK (0.98) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL21135590 | 0.92 | ALK (0.84) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL897863 | 0.91 | ALK (1.00) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL897814 | 0.91 | ALK (0.83) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL29962312 | 0.91 | ALK (0.83) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL898155 | 0.91 | ALK (1.00) | ALKEML4KDRSRPK2SRPK1 | |
| SCHEMBL897724 | 0.90 | ALK (0.91) | ALKEML4KDRSRPK2SRPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745138-A1 | THIO-GLUTARIMIDO ISOINDOLINONE DERIVATIVE, BIFUNCTIONAL PROTEIN DEGRADER CONTAINING SAME, AND USES THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | disclosed |
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |
| CN-120202200-A | Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof | 标新生物医药科技(上海)有限公司 | 2025-06-24 | — | — | CN | disclosed |
| WO-2024245443-A1 | COMPOUND BASED ON OXOISOINDOLINYL SUBSTITUTED TETRAHYDRO-2-PYRIMIDONE, AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-12-05 | — | — | WO | disclosed |
| EP-4446324-A1 | LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024188209-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-09-19 | — | — | WO | disclosed |
| CN-116239566-A | E3 ubiquitin ligase ligand compound, protein degradation agent developed based on ligand compound and application thereof | 标新生物医药科技(上海)有限公司 | 2023-06-09 | — | — | CN | disclosed |
| EP-2975024-B1 | TETRACYCLIC COMPOUNDS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2018-03-28 | — | — | EP | disclosed |